Scynexis (SCYX) Free Cash Flow (2013 - 2026)
Scynexis' (SCYX) quarterly Free Cash Flow came in at -$8.1 million in Q1 2026, down 8.52% YoY from -$8.9 million in Q1 2025, and down 144.02% on a QoQ basis from $18.4 million in Q4 2025.
Scynexis (SCYX) Free Cash Flow (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Free Cash Flow data on file, last reported at -$8.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 8.52% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (up 78.45% YoY) and the FY2025 annual result came in at -$5.3 million, up 78.0% from the prior year.
- Free Cash Flow declined to -$8.1 million in Q1 2026, from $18.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $74.4 million in Q2 2023 to a low of -$22.8 million in Q4 2022.
- A 5-year average of -$3.4 million and a median of -$8.1 million in 2026 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 1606.3% — and 2023, when it surged 500.4%.
- Tracing SCYX's Free Cash Flow over 5 years: stood at -$22.8 million in 2022, then jumped by 66.08% to -$7.7 million in 2023, then decreased by 28.08% to -$9.9 million in 2024, then jumped by 285.74% to $18.4 million in 2025, then sank by 144.02% to -$8.1 million in 2026.
- The last three Free Cash Flow figures came in at -$8.1 million (Q1 2026), $18.4 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | -14.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.89 Mn |
| Jun 30, 2026 | -14.89 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Sep 30, 2024 | 765,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | -10.86 Mn |
| Jun 30, 2024 | -10.86 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |